A Look at Treatment Strategies for High-Risk AML Patients
https://vimeo.com/794306813 What acute myeloid leukemia (AML) treatments are available for high-risk patients? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center discusses various mutations, potential for cure,…
Why Is the Menin Pathway Important in AML?
https://vimeo.com/794306732 What should acute myeloid leukemia (AML) patients know about the menin pathway? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center shares information from ASH 2022….
The Importance of the FLT3 Mutation in AML
https://vimeo.com/794306585 What do acute myeloid leukemia (AML) patients need to know about FLT3 mutation? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center discusses considerations about the…
What Different AML Subtypes Are More Prevalent in Certain Demographics?
https://vimeo.com/794307429 Are some acute myeloid leukemia (AML) subtypes more common in some demographic groups? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center discusses different forms of…
AML Treatment Approaches Expand for Older and High-Risk Patients
https://vimeo.com/794306507 How have acute myeloid leukemia (AML) treatment approaches expanded for older and high-risk patients? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center shares insight about…
What Promising AML Treatments Are Available for Newly Diagnosed Patients?
https://vimeo.com/794306419 What do newly diagnosed acute myeloid leukemia (AML) patients have for promising treatment options? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center discusses progress in…
How Can We Address Disparities in AML Among Diverse Populations?
https://vimeo.com/792475469 What do acute myeloid leukemia (AML) patients need to know about care disparities? Dr. Catherine Lai from Penn Medicine discusses ethnic disparities and other factors. Learn about factors in…
Long-Term Effects Acute Myeloid Leukemia Patients Should Know
https://vimeo.com/792475443 What do acute myeloid leukemia (AML) need to know about potential long-term effects of treatment? Dr. Catherine Lai from Penn Medicine shares insight. Learn about medical considerations for monitoring…
What Are Some Clinical Predictors for Relapse in Acute Myeloid Leukemia?
https://vimeo.com/792474847 What do acute myeloid leukemia (AML) patients need to know about risk of relapse? Dr. Catherine Lai from Penn Medicine explains her perspective. Learn about relapse risk groups and…
What Does Transfusion Burden Mean in Acute Myeloid Leukemia?
https://vimeo.com/792474680 What do acute myeloid leukemia (AML) patients need to know about transfusion burden? Dr. Catherine Lai from Penn Medicine explains transfusion burden for AML patients. Learn about the range…
Assessing Untreated AML Patients Who Are Ineligible for Intensive Chemotherapy
https://vimeo.com/792474641 How are acute myeloid leukemia (AML) patients assessed for intensive chemotherapy? Dr. Catherine Lai from Penn Medicine explains eligibility criteria. Learn factors that impact patient eligibility and treatment options…
What AML Treatment Options Are Available for MRD-Positive Patients?
https://vimeo.com/792474010 For acute myeloid leukemia (AML) patients who are MRD-positive, what treatment options are available? Dr. Catherine Lai from Penn Medicine discusses MRD-positive concerns. Learn about recent guideline updates for…